The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Parenteral Nutrition Carbohydrates Market Research Report 2024

Global Parenteral Nutrition Carbohydrates Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1763728

No of Pages : 96

Ask Your Query

Synopsis
Parenteral nutrition (PN) is a method of providing essential nutrients, including carbohydrates, directly into the bloodstream through intravenous (IV) infusion. This approach is used when a person is unable to consume adequate nutrients orally or through the gastrointestinal tract.

Global Parenteral Nutrition Carbohydrates market is projected to reach US$ 5202 million in 2029, increasing from US$ 3125 million in 2022, with the CAGR of 8.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Parenteral Nutrition Carbohydrates market research.

Key manufacturers engaged in the Parenteral Nutrition Carbohydrates industry include Fresenius Kabi, Baxter, B. Braun, Kelun Pharma, Otsuka Pharmaceutical, Haisco Pharmaceutical Group, King York, Cisen and Lummy Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Parenteral Nutrition Carbohydrates were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Parenteral Nutrition Carbohydrates market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Parenteral Nutrition Carbohydrates market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Fresenius Kabi
  • Baxter
  • B. Braun
  • Kelun Pharma
  • Otsuka Pharmaceutical
  • Haisco Pharmaceutical Group
  • King York
  • Cisen
  • Lummy Pharmaceutical
  • Grand Life Sciences
  • BBCA Pharmaceutical
  • Biokin Pharmaceutical
  • Xi'an Libang Pharmaceutical

Segment by Type

  • Glucose
  • Fructose
  • Invert Sugar

Segment by Application

  • 100ml and Below
  • 250ml
  • 500ml
  • 1L and Above

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Parenteral Nutrition Carbohydrates report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Parenteral Nutrition Carbohydrates Market Overview
1.1 Product Overview and Scope of Parenteral Nutrition Carbohydrates
1.2 Parenteral Nutrition Carbohydrates Segment by Type
1.2.1 Global Parenteral Nutrition Carbohydrates Market Value Comparison by Type (2023-2029)
1.2.2 Glucose
1.2.3 Fructose
1.2.4 Invert Sugar
1.3 Parenteral Nutrition Carbohydrates Segment by Application
1.3.1 Global Parenteral Nutrition Carbohydrates Market Value by Application: (2023-2029)
1.3.2 100ml and Below
1.3.3 250ml
1.3.4 500ml
1.3.5 1L and Above
1.4 Global Parenteral Nutrition Carbohydrates Market Size Estimates and Forecasts
1.4.1 Global Parenteral Nutrition Carbohydrates Revenue 2018-2029
1.4.2 Global Parenteral Nutrition Carbohydrates Sales 2018-2029
1.4.3 Global Parenteral Nutrition Carbohydrates Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Parenteral Nutrition Carbohydrates Market Competition by Manufacturers
2.1 Global Parenteral Nutrition Carbohydrates Sales Market Share by Manufacturers (2018-2023)
2.2 Global Parenteral Nutrition Carbohydrates Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Parenteral Nutrition Carbohydrates Average Price by Manufacturers (2018-2023)
2.4 Global Parenteral Nutrition Carbohydrates Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Parenteral Nutrition Carbohydrates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parenteral Nutrition Carbohydrates, Product Type & Application
2.7 Parenteral Nutrition Carbohydrates Market Competitive Situation and Trends
2.7.1 Parenteral Nutrition Carbohydrates Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Parenteral Nutrition Carbohydrates Players Market Share by Revenue
2.7.3 Global Parenteral Nutrition Carbohydrates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parenteral Nutrition Carbohydrates Retrospective Market Scenario by Region
3.1 Global Parenteral Nutrition Carbohydrates Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Parenteral Nutrition Carbohydrates Global Parenteral Nutrition Carbohydrates Sales by Region: 2018-2029
3.2.1 Global Parenteral Nutrition Carbohydrates Sales by Region: 2018-2023
3.2.2 Global Parenteral Nutrition Carbohydrates Sales by Region: 2024-2029
3.3 Global Parenteral Nutrition Carbohydrates Global Parenteral Nutrition Carbohydrates Revenue by Region: 2018-2029
3.3.1 Global Parenteral Nutrition Carbohydrates Revenue by Region: 2018-2023
3.3.2 Global Parenteral Nutrition Carbohydrates Revenue by Region: 2024-2029
3.4 North America Parenteral Nutrition Carbohydrates Market Facts & Figures by Country
3.4.1 North America Parenteral Nutrition Carbohydrates Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Parenteral Nutrition Carbohydrates Sales by Country (2018-2029)
3.4.3 North America Parenteral Nutrition Carbohydrates Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Parenteral Nutrition Carbohydrates Market Facts & Figures by Country
3.5.1 Europe Parenteral Nutrition Carbohydrates Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Parenteral Nutrition Carbohydrates Sales by Country (2018-2029)
3.5.3 Europe Parenteral Nutrition Carbohydrates Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral Nutrition Carbohydrates Market Facts & Figures by Country
3.6.1 Asia Pacific Parenteral Nutrition Carbohydrates Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Parenteral Nutrition Carbohydrates Sales by Country (2018-2029)
3.6.3 Asia Pacific Parenteral Nutrition Carbohydrates Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Parenteral Nutrition Carbohydrates Market Facts & Figures by Country
3.7.1 Latin America Parenteral Nutrition Carbohydrates Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Parenteral Nutrition Carbohydrates Sales by Country (2018-2029)
3.7.3 Latin America Parenteral Nutrition Carbohydrates Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Parenteral Nutrition Carbohydrates Market Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral Nutrition Carbohydrates Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Parenteral Nutrition Carbohydrates Sales by Country (2018-2029)
3.8.3 Middle East and Africa Parenteral Nutrition Carbohydrates Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Parenteral Nutrition Carbohydrates Sales by Type (2018-2029)
4.1.1 Global Parenteral Nutrition Carbohydrates Sales by Type (2018-2023)
4.1.2 Global Parenteral Nutrition Carbohydrates Sales by Type (2024-2029)
4.1.3 Global Parenteral Nutrition Carbohydrates Sales Market Share by Type (2018-2029)
4.2 Global Parenteral Nutrition Carbohydrates Revenue by Type (2018-2029)
4.2.1 Global Parenteral Nutrition Carbohydrates Revenue by Type (2018-2023)
4.2.2 Global Parenteral Nutrition Carbohydrates Revenue by Type (2024-2029)
4.2.3 Global Parenteral Nutrition Carbohydrates Revenue Market Share by Type (2018-2029)
4.3 Global Parenteral Nutrition Carbohydrates Price by Type (2018-2029)
5 Segment by Application
5.1 Global Parenteral Nutrition Carbohydrates Sales by Application (2018-2029)
5.1.1 Global Parenteral Nutrition Carbohydrates Sales by Application (2018-2023)
5.1.2 Global Parenteral Nutrition Carbohydrates Sales by Application (2024-2029)
5.1.3 Global Parenteral Nutrition Carbohydrates Sales Market Share by Application (2018-2029)
5.2 Global Parenteral Nutrition Carbohydrates Revenue by Application (2018-2029)
5.2.1 Global Parenteral Nutrition Carbohydrates Revenue by Application (2018-2023)
5.2.2 Global Parenteral Nutrition Carbohydrates Revenue by Application (2024-2029)
5.2.3 Global Parenteral Nutrition Carbohydrates Revenue Market Share by Application (2018-2029)
5.3 Global Parenteral Nutrition Carbohydrates Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Fresenius Kabi
6.1.1 Fresenius Kabi Corporation Information
6.1.2 Fresenius Kabi Description and Business Overview
6.1.3 Fresenius Kabi Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Fresenius Kabi Parenteral Nutrition Carbohydrates Product Portfolio
6.1.5 Fresenius Kabi Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter Parenteral Nutrition Carbohydrates Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.3.4 B. Braun Parenteral Nutrition Carbohydrates Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Kelun Pharma
6.4.1 Kelun Pharma Corporation Information
6.4.2 Kelun Pharma Description and Business Overview
6.4.3 Kelun Pharma Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kelun Pharma Parenteral Nutrition Carbohydrates Product Portfolio
6.4.5 Kelun Pharma Recent Developments/Updates
6.5 Otsuka Pharmaceutical
6.5.1 Otsuka Pharmaceutical Corporation Information
6.5.2 Otsuka Pharmaceutical Description and Business Overview
6.5.3 Otsuka Pharmaceutical Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Otsuka Pharmaceutical Parenteral Nutrition Carbohydrates Product Portfolio
6.5.5 Otsuka Pharmaceutical Recent Developments/Updates
6.6 Haisco Pharmaceutical Group
6.6.1 Haisco Pharmaceutical Group Corporation Information
6.6.2 Haisco Pharmaceutical Group Description and Business Overview
6.6.3 Haisco Pharmaceutical Group Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Haisco Pharmaceutical Group Parenteral Nutrition Carbohydrates Product Portfolio
6.6.5 Haisco Pharmaceutical Group Recent Developments/Updates
6.7 King York
6.6.1 King York Corporation Information
6.6.2 King York Description and Business Overview
6.6.3 King York Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.4.4 King York Parenteral Nutrition Carbohydrates Product Portfolio
6.7.5 King York Recent Developments/Updates
6.8 Cisen
6.8.1 Cisen Corporation Information
6.8.2 Cisen Description and Business Overview
6.8.3 Cisen Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cisen Parenteral Nutrition Carbohydrates Product Portfolio
6.8.5 Cisen Recent Developments/Updates
6.9 Lummy Pharmaceutical
6.9.1 Lummy Pharmaceutical Corporation Information
6.9.2 Lummy Pharmaceutical Description and Business Overview
6.9.3 Lummy Pharmaceutical Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Lummy Pharmaceutical Parenteral Nutrition Carbohydrates Product Portfolio
6.9.5 Lummy Pharmaceutical Recent Developments/Updates
6.10 Grand Life Sciences
6.10.1 Grand Life Sciences Corporation Information
6.10.2 Grand Life Sciences Description and Business Overview
6.10.3 Grand Life Sciences Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Grand Life Sciences Parenteral Nutrition Carbohydrates Product Portfolio
6.10.5 Grand Life Sciences Recent Developments/Updates
6.11 BBCA Pharmaceutical
6.11.1 BBCA Pharmaceutical Corporation Information
6.11.2 BBCA Pharmaceutical Parenteral Nutrition Carbohydrates Description and Business Overview
6.11.3 BBCA Pharmaceutical Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.11.4 BBCA Pharmaceutical Parenteral Nutrition Carbohydrates Product Portfolio
6.11.5 BBCA Pharmaceutical Recent Developments/Updates
6.12 Biokin Pharmaceutical
6.12.1 Biokin Pharmaceutical Corporation Information
6.12.2 Biokin Pharmaceutical Parenteral Nutrition Carbohydrates Description and Business Overview
6.12.3 Biokin Pharmaceutical Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Biokin Pharmaceutical Parenteral Nutrition Carbohydrates Product Portfolio
6.12.5 Biokin Pharmaceutical Recent Developments/Updates
6.13 Xi'an Libang Pharmaceutical
6.13.1 Xi'an Libang Pharmaceutical Corporation Information
6.13.2 Xi'an Libang Pharmaceutical Parenteral Nutrition Carbohydrates Description and Business Overview
6.13.3 Xi'an Libang Pharmaceutical Parenteral Nutrition Carbohydrates Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Xi'an Libang Pharmaceutical Parenteral Nutrition Carbohydrates Product Portfolio
6.13.5 Xi'an Libang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral Nutrition Carbohydrates Industry Chain Analysis
7.2 Parenteral Nutrition Carbohydrates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral Nutrition Carbohydrates Production Mode & Process
7.4 Parenteral Nutrition Carbohydrates Sales and Marketing
7.4.1 Parenteral Nutrition Carbohydrates Sales Channels
7.4.2 Parenteral Nutrition Carbohydrates Distributors
7.5 Parenteral Nutrition Carbohydrates Customers
8 Parenteral Nutrition Carbohydrates Market Dynamics
8.1 Parenteral Nutrition Carbohydrates Industry Trends
8.2 Parenteral Nutrition Carbohydrates Market Drivers
8.3 Parenteral Nutrition Carbohydrates Market Challenges
8.4 Parenteral Nutrition Carbohydrates Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock